Stockreport

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

Eterna Therapeutics Inc.  (ERNA) 
PDF CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors h [Read more]